Hepcidin: The Missing Link between Hemochromatosis and Infections

Infection and Immunity

Volumn 71, Issue 12, 2003, Pages 6693-6700

  Ashrafian, Houman ^a  

^a EALING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HEPCIDIN; IRON; SIDEROPHORE;

ACID FAST BACTERIUM; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOCHROMATOSIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOON; SHORT SURVEY; VIBRIO VULNIFICUS;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; HEMOCHROMATOSIS; HUMANS; IRON; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 0344420199     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.12.6693-6700.2003     Document Type: Short Survey

References (90)

1. Abbott, M., A. Galloway, and J. L. Cunningham. 1986. Haemochromatosis presenting with a double Yersinia infection. J. Infect. 13:143-145.
2. Amako, K., K. Okada, and S. Miake. 1984. Evidence for the presence of a capsule in Vibrio vulnificus. J. Gen. Microbiol. 130:2741-2743.
3. Andersen, B. R. 1975. Host factors causing increased susceptibility to infection in patients with Laennec's cirrhosis. Ann. N. Y. Acad. Sci. 252:348-352.
4. Barnewall, R. E., N. Ohashi, and Y. Rikihisa. 1999. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect. Immun. 67:2258-2265.
5. Baumler, A. J., and K. Hantke. 1992. Ferrioxamine uptake in Yersinia enterocolitica: characterization of the receptor protein FoxA. Mol. Microbiol. 6:1309-1321.
6. Blake, P. A., M. H. Merson, R. E. Weaver, D. G. Hollis, and P. C. Heublein. 1979. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N. Engl. J. Med. 300:1-5.
7. Bogdan, C. 2001. Nitric oxide and the regulation of gene expression. Trends Cell Biol. 11:66-75.
8. Bomford, A. 2002. Genetics of haemochromatosis. Lancet 360:1673-1681.
9. Bottone, E. J. 1999. Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect. 1:323-333.
10. Bridle, K. R., D. M. Frazer, S. J. Wilkins, J. L. Dixon, D. M. Purdie, D. H. Crawford, V. N. Subramaniam, L.W. Powell, G. J. Anderson, and G. A. Ram. 2003. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669-673.
11. Bullen, J. J., P. B. Spalding, C. G. Ward, and J. M. Gutteridge. 1991. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch. Intern. Med. 151:1606-1609.
12. Carniel, E. 2001. The Yersinia high-pathogenicity island: an iron-uptake island. Microbes Infect. 3:561-569.
13. Clarke, T. E., L. W. Tari, and H. J. Vogel. 2001. Structural biology of bacterial iron uptake systems. Curr. Top. Med. Chem. 1:7-30.
14. Corke, P. J., A. S. McLean, D. Stewart, and S. Adams. 1995. Overwhelming gram negative septic shock in haemochromatosis. Anaesth. Intensive Care 23:346-349.
15. Cornelis, G. R. 1998. The Yersinia deadly kiss. J. Bacteriol. 180:5495-5504.
16. Cornelis, G. R., A. Boland, A. P. Boyd, C. Geuijen, M. Iriarte, C. Neyt, M. P. Sory, and I. Stainier. 1998. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62:1315-1352.
17. Cornelissen, C. N. 2003. Transferrin-iron uptake by Gram-negative bacteria. Front. Biosci. 8:d836-d847.
18. Davis, J. W., and R. K. Sizemore. 1982. Incidence of Vibrio species associated with blue crabs (Callinectes sapidus) collected from Galveston Bay, Texas. Appl. Environ. Microbiol. 43:1092-1097.
19. de Sousa, M., R. Reimao, G. Porto, R. W. Grady, M. W. Hilgartner, and P. Giardina. 1991. Iron and lymphocytes: reciprocal regulatory interactions. Curr. Stud. Hematol. Blood Transfus. 58:171-177.
20. Douglas, S. E., J. W. Gallant, R. S. Liebscher, A. Dacanay, and S. C. Tsoi. 2003. Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish. Dev. Comp. Immunol. 27:589-601.
21. Fan, J. J., C. P. Shao, Y. C. Ho, C. K. Yu, and L. I. Hor. 2001. Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin. Infect. Immun. 69:5943-5948.
22. Faraldo-Gomez, J. D., and M. S. Sansom. 2003. Acquisition of siderophores in gram-negative bacteria. Nat. Rev. Mol. Cell Biol. 4:105-116.
23. Ganz, T. 2003. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783-788.
24. George, M. J., J. A. DeBin, K. E. Preston, C. Chiu, and S. S. Haqqie. 1996. Recurrent bacterial peritonitis caused by Neisseria cinerea in a chronic ambulatory peritoneal dialysis (CAPD) patient. Diagn. Microbiol. Infect. Dis. 26:91-93.
25. Gladstone, G. P., and E. Walton. 1970. Effect of iron on the bactericidal proteins from rabbit polymorphonuclear leukocytes. Nature 227:849-851.
26. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
27. Gomez, F., P. Ruiz, and A. D. Schreiber. 1994. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N. Engl. J. Med. 331:1122-1128.
28. Homann, C., K. Varming, K. Hogasen, T. E. Mollnes, N. Graudal, A. C. Thomsen, and P. Garred. 1997. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 40:544-549.
29. Jeong, K. C., H. S. Jeong, J. H. Rhee, S. E. Lee, S. S. Chung, A. M. Starks, G. M. Escudero, P. A. Gulig, and S. H. Choi. 2000. Construction and phenotypic evaluation of a Vibrio vulnificus vvpE mutant for elastolytic protease. Infect. Immun. 68:5096-5106.
30. Johnson, R. W., and F. C. Arnett. 2001. A fatal case of Vibrio vulnificus presenting as septic arthritis. Arch. Intern. Med. 161:2616-2618.
31. Johnston, J. M., S. F. Becker, and L. M. McFarland. 1985. Vibrio vulnificus. Man and the sea. JAMA 253:2850-2853.
32. Kelly, D. A., E. Price, B. Jani, V. Wright, M. Rossiter, and J. A. Walker. Smith. 1987. Yersinia enterocolitis in iron overload. J. Pediatr. Gastroenterol. Nutr. 6:643-645.
33. Kizer, K. W. 1994. Vibrio vulnificus hazard in patients with liver disease. West. J. Med. 161:64-65.
34. Klebba, P. E., and S. M. Newton. 1998. Mechanisms of solute transport through outer membrane porins: burning down the house. Curr. Opin. Microbiol. 1:238-247.
35. Krause, A., S. Neitz, H. J. Magert, A. Schulz, W. G. Forssmann, P. Schulz-Knappe, and K. Adermann. 2000. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480:147-150.
36. Kuvibidila, S., and B. S. Baliga. 2002. Role of iron in immunity and infection, p. 209-228. In P. C. Calder, C. J. Field, and H. S. Gill (ed.), Nutrition and immune function. CABI Publishing, Oxon, United Kingdom.
37. Lehrer, R. I., T. Ganz, D. Szklarek, and M. E. Selsted. 1988. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Investig. 81:1829-1835.
38. Levine, W. C., P. M. Griffin, et al. 1993. Vibrio infections on the Gulf Coast: results of first year of regional surveillance. J. Infect. Dis. 167:479-483.
39. Linkous, D. A., and J. D. Oliver. 1999. Pathogenesis of Vibro vulnificus. FEMS Microbiol. Lett. 174:207-214.
40. Litwin, C. M., and B. L. Byrne. 1998. Cloning and characterization of an outer membrane protein of Vibrio vulnificus required for heme utilization: regulation of expression and determination of the gene sequence. Infect. Immun. 66:3134-3141.
41. Litwin, C. M., T. W. Rayback, and J. Skinner. 1996. Role of catechol siderophore synthesis in Vibrio vulnificus virulence. Infect. Immun. 64:2834-2838.
42. MacGregor, R. R. 1999. Alcohol abuse, host defenses and infection, p. 853-857. In R. K. Root, F. Waldvogel, L. Corey, and W. E. Stamm (ed.), Clinical infectious diseases: a practical approach. Oxford University Press USA, New York, N.Y.
43. Manso, C., I. Rivas, J. Peraire, F. Vidal, and C. Richart. 1997. Fatal Listeria meningitis, endocarditis and pericarditis in a patient with haemochromatosis. Scand. J. Infect. Dis. 29:308-309.
44. Marx, J. J. 2002. Iron and infection: competition between host and microbes for a precious element. Best Pract. Res. Clin. Haematol. 15:411-426.
45. Mazoy, R., E. M. Lopez, B. Fouz, C. Amaro, and M. L. Lemos. 1999. Ferric-reductase activities in Vibrio vulnificus biotypes 1 and 2. FEMS Microbiol. Lett. 172:205-211.
46. McPherson, V. L., J. A. Watts, L. M. Simpson, and J. D. Oliver. 1991. Physiological effects of the lipopolysaccharide of Vibrio vulnificus on mice and rats. Microbios 67:141-149.
47. Mellencamp, M. A., and L. C. Preheim. 1991. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J. Infect. Dis. 163:102-108.
48. Morris, J. G., Jr. 1988. Vibrio vulnificus-a new monster of the deep? Ann. Intern. Med. 109:261-263.
49. Morris, J. G., Jr., and R. E. Black. 1985. Cholera and other vibrioses in the United States. N. Engl. J. Med. 312:343-350.
50. Moura, E., A. F. Verheul, and J. J. Marx. 1998. A functional defect in hereditary haemochromatosis monocytes and monocyte-derived macrophages. Eur. J. Clin. Investig. 28:164-173.
51. Muench, K. H. 1989. Hemochromatosis and infection: alcohol and iron, oysters and sepsis. Am. J. Med. 87:40N-43N.
52. Nemeth, E., E. V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463.
53. Nicolas, G., M. Bennoun, I. Devaux, C. Beaumont, B. Grandchamp, A. Kahn, and S. Vaulont. 2001. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98:8780-8785.
54. Nicolas, G., M. Bennoun, A. Porteu, S. Mativet, C. Beaumont, B. Grandchamp, M. Sirito, M. Sawadogo, A. Kahn, and S. Vaulont. 2002. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99:4596-4601.
55. Paranjpye, R. N., J. C. Lara, J. C. Pepe, C. M. Pepe, and M. S. Strom. 1998. The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded mice. Infect. Immun. 66:5659-5668.
56. Park, C. H., E. V. Valore, A. J. Waring, and T. Ganz. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276: 7806-7810.
57. Pigeon, C., G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot, and O. Loreal. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276:7811-7819.
58. Powell, J. L., A. C. Wright, S. S. Wasserman, D. M. Hone, and J. G. Morris, Jr. 1997. Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect. Immun. 65:3713-3718.
59. Recalcati, S., R. Pometta, S. Levi, D. Conte, and G. Cairo. 1998. Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood 91:2565-2572.
60. Rimola, A., R. Soto, F. Bory, V. Arroyo, C. Piera, and J. Rodes. 1984. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4:53-58.
61. Robins-Browne, R. M., and J. K. Prpic. 1985. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect. Immun. 47:774-779.
62. Roetto, A., G. Papanikolaou, M. Politou, F. Alberti, D. Girelli, J. Christakis, D. Loukopoulos, and C. Camaschella. 2003. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33:21-22.
63. Santoro, M. J., Y. K. Chen, N. S. Seid, J. D. Abdulian, and M. J. Collen. 1994. Yersinia enterocolitica liver abscesses unmasking idiopathic hemochromatosis. J. Clin. Gastroenterol. 18:253-254.
64. Shao, C. P., and L. I. Hor. 2000. Metalloprotease is not essential for Vibrio vulnificus virulence in mice. Infect. Immun. 68:3569-3573.
65. Shapiro, R. L., S. Altekruse, L. Hutwagner, R. Bishop, R. Hammond, S. Wilson, B. Ray, S. Thompson, R. V. Tauxe, P. M. Griffin, et al. 1998. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. J. Infect. Dis. 178:752-759.
66. Shike, H., X. Lauth, M. E. Westerman, V. E. Ostland, J. M. Carlberg, J. C. Van Olst, C. Shimizu, P. Bulet, and J. C. Burns. 2002. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur. J. Biochem. 269:2232-2237.
67. Shinoda, S., M. Kobayashi, H. Yamada, S. Yoshida, M. Ogawa, and Y. Mizuguchi. 1987. Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum. Microbiol. Immunol. 31:393-401.
68. Starks, A. M., T. R. Schoeb, M. L. Tamplin, S. Parveen, T. J. Doyle, P. E. Bomeisl, G. M. Escudero, and P. A. Gulig. 2000. Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice. Infect. Immun. 68:5785-5793.
69. Strom, M. S., and R. N. Paranjpye. 2000. Epidemiology and pathogenesis of Vibtio vulnificus. Microbes Infect. 2:177-188.
70. Strungs, I., D. J. Farrell, L. D. Matar, L. Dekker, and R. J. Franz. 1995. Multiple hepatic abscesses due to Yersinia enterocolitica. Pathology 27:374-377.
71. Tacket, C. O., F. Brenner, and P. A. Blake. 1984. Clinical features and an epidemiological study of Vibrio vulnificus infections. J. Infect. Dis. 149:558-561.
72. Tamplin, M., G. E. Rodrick, N. J. Blake, and T. Cuba. 1982. Isolation and characterization of Vibrio vulnificus from two Florida estuaries. Appl. Environ. Microbiol. 44:1466-1470.
73. Tamplin, M. L., S. Specter, G. E. Rodrick, and H. Friedman. 1983. Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect. Immun. 42:1187-1190.
74. Tamplin, M. L., S. Specter, G. E. Rodrick, and H. Friedman. 1985. Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect. Immun. 49:715-718.
75. Touati, D. 2000. Iron and oxidative stress in bacteria. Arch. Biochem. Biophys. 373:1-6.
76. Vadillo, M., X. Corbella, V. Pac, P. Fernandez-Viladrich, and R. Pujol. 1994. Multiple liver abscesses due to Yersinia enterocolitica discloses primary hemochromatosis: three cases reports and review. Clin. Infect. Dis. 18:938-941.
77. van Asbeck, B. S., J. J. Marx, A. Struyvenberg, and J. Verhoef. 1984. Functional defects in phagocytic cells from patients with iron overload. J. Infect. 8:232-240.
78. van Asbeck, B. S., H. A. Verbrugh, B. A. van Oost, J. J. Marx, H. W. Imhof, and J. Verhoef. 1982. Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br. Med. J. (Clin. Res. Ed.) 284:542-544.
79. Walker, E. M., Jr., and S. M. Walker. 2000. Effects of iron overload on the immune system. Ann. Clin. Lab. Sci. 30:354-365.
80. Webster, A. C., and C. M. Litwin. 2000. Cloning and characterization of vuuA, a gene encoding the Vibrio vulnificus ferric vulnibactin receptor. Infect. Immun. 68:526-534.
81. Weinberg, E. D. 1999. Iron loading and disease surveillance. Emerg. Infect. Dis. 5:346-352.
82. Weinberg, E. D. 2000. Microbial pathogens with impaired ability to acquire host iron. Biometals 13:85-89.
83. Weinberg, E. D. 2000. Modulation of intramacrophage iron metabolism during microbial cell invasion. Microbes Infect. 2:85-89.
84. Weinstein, D. A., C. N. Roy, M. D. Fleming, M. F. Loda, J. I. Wolfsdorf, and N. C. Andrews. 2002. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100:3776-3781.
85. Weiss, G. 2002. Iron and immunity: a double-edged sword. Eur. J. Clin. Investig. 32(Suppl. 1):70-78.
86. Weiss, G., D. Fuchs, A. Hausen, G. Reibnegger, E. R. Werner, G. Werner-Felmayer, and H. Wachter. 1992. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp. Hematol. 20:605-610.
87. Winkelmann, G. 2002. Microbial siderophore-mediated transport. Biochem. Soc. Trans. 30:691-696.
88. Wright, A. C., and J. G. Morris, Jr. 1991. The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect. Immun. 59:192-197.
89. Wright, A. C., L. M. Simpson, and J. D. Oliver. 1981. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect. Immun. 34:503-507.
90. Zwilling, B. S., D. E. Kuhn, L. Wikoff, D. Brown, and W. Lafuse. 1999. Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect. Immun. 67:1386-1392.